| RS886039511 |
APC
|
Health Risk |
Likely pathogenic |
— |
| RS886039512 |
CHEK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS886039513 |
TUBA1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Tubulinopathy, Cerebral palsy |
| RS886039515 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS886039516 |
UBE3A
|
Health Risk |
Pathogenic |
Angelman syndrome, Angelman syndrome |
| RS886039517 |
SLC2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Encephalopathy due to GLUT1 deficiency, GLUT1 deficiency syndrome 1 |
| RS886039518 |
OCRL
|
Health Risk |
Pathogenic |
Lowe syndrome, Lowe syndrome |
| RS886039519 |
OCRL
|
Health Risk |
Pathogenic |
Lowe syndrome, Lowe syndrome |
| RS886039520 |
SMARCB1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 15 |
| RS886039522 |
MTM1
|
Health Risk |
Pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS886039523 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS886039524 |
FAS
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS886039526 |
CHD7
|
Health Risk |
Pathogenic |
CHD7-related CHARGE syndrome, CHD7-related CHARGE syndrome |
| RS886039527 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS886039528 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS886039529 |
SCN1A
|
Health Risk |
Pathogenic |
Seizure, Seizure |
| RS886039530 |
ATP1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Epileptic encephalopathy, Familial hemiplegic migraine |
| RS886039531 |
NIPBL
|
Health Risk |
Pathogenic |
— |
| RS886039532 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS886039533 |
DMD
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS886039534 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS886039535 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS886039536 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Cardiomyopathy |
| RS886039537 |
PLP1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 2, Hereditary spastic paraplegia 2 |
| RS886039539 |
JAG1
|
Health Risk |
Pathogenic |
Arteriohepatic dysplasia, Arteriohepatic dysplasia |
| RS886039540 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Gorlin syndrome |
| RS886039541 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS886039542 |
COL2A1
|
Health Risk |
Likely pathogenic |
Spondylometaphyseal dysplasia - Sutcliffe type, Type 2 collagenopathy |
| RS886039543 |
COL2A1
|
Health Risk |
Pathogenic |
COL2A1-related disorder, COL2A1-related disorder |
| RS886039544 |
HNF1A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young, Monogenic diabetes |
| RS886039545 |
RPS24
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS886039546 |
STAT3
|
Health Risk |
Conflicting classifications of pathogenicity |
STAT3 gain of function, Hyper-IgE recurrent infection syndrome 1 |
| RS886039547 |
SPINK5
|
Health Risk |
Pathogenic |
— |
| RS886039548 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS886039549 |
FBN1
|
Health Risk |
Pathogenic |
— |
| RS886039550 |
FBN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Marfan syndrome, Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections |
| RS886039551 |
TGFBR2
|
Health Risk |
Pathogenic/Likely pathogenic |
Loeys-Dietz syndrome 1, Familial thoracic aortic aneurysm and aortic dissection |
| RS886039552 |
PLA2G6
|
Health Risk |
Pathogenic |
Infantile neuroaxonal dystrophy, Neurodegeneration with brain iron accumulation |
| RS886039553 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS886039554 |
STK11
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Peutz-Jeghers syndrome |
| RS886039555 |
BTK
|
Health Risk |
Pathogenic |
X-linked agammaglobulinemia with growth hormone deficiency, X-linked agammaglobulinemia |
| RS886039557 |
ACTA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS886039558 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS886039559 |
CACNA1F
|
Health Risk |
Pathogenic |
Aland island eye disease, Congenital stationary night blindness 2A |
| RS886039560 |
CACNA1F
|
Health Risk |
Pathogenic |
Congenital stationary night blindness 2A, X-linked cone-rod dystrophy 3 |
| RS886039561 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS886039562 |
COL7A1
|
Health Risk |
Pathogenic/Likely pathogenic |
7 conditions, 7 conditions |
| RS886039563 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS886039564 |
EDAR
|
Health Risk |
Pathogenic |
Autosomal recessive hypohidrotic ectodermal dysplasia syndrome, Ectodermal dysplasia 10A |
| RS886039565 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS886039566 |
EXT2
|
Health Risk |
Pathogenic |
— |
| RS886039567 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS886039568 |
FOXC1
|
Health Risk |
Pathogenic |
Axenfeld-Rieger syndrome type 3, Axenfeld-Rieger syndrome type 3 |
| RS886039569 |
GALC
|
Health Risk |
Pathogenic/Likely pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS886039570 |
IRF6
|
Health Risk |
Pathogenic |
— |
| RS886039571 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS886039572 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS886039573 |
DYSF
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS886039574 |
LMX1B
|
Health Risk |
Pathogenic |
— |
| RS886039575 |
ZNF469
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS886039576 |
LMX1B
|
Health Risk |
Pathogenic |
Nail-patella syndrome, Nail-patella syndrome |
| RS886039578 |
NSD1
|
Health Risk |
Pathogenic |
— |
| RS886039579 |
NSD1
|
Health Risk |
Pathogenic |
— |
| RS886039580 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS886039581 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS886039582 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS886039583 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS886039584 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS886039585 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS886039586 |
RYR1
|
Health Risk |
Pathogenic/Likely pathogenic |
RYR1-related disorder, Abnormality of the musculature |
| RS886039590 |
CDH1
|
Health Risk |
Pathogenic |
Hereditary diffuse gastric adenocarcinoma, CDH1-related diffuse gastric and lobular breast cancer syndrome |
| RS886039591 |
ATM
|
Health Risk |
Likely pathogenic |
— |
| RS886039592 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS886039594 |
ARID1B
|
Health Risk |
Likely pathogenic |
— |
| RS886039595 |
SGCE
|
Health Risk |
Pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS886039597 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy |
| RS886039598 |
PEX26
|
Health Risk |
Likely pathogenic |
— |
| RS886039599 |
MED13L
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiac anomalies - developmental delay - facial dysmorphism syndrome, Cardiac anomalies - developmental delay - facial dysmorphism syndrome |
| RS886039600 |
CTCF
|
Health Risk |
Likely pathogenic |
— |
| RS886039601 |
EZH2
|
Health Risk |
Likely pathogenic |
— |
| RS886039602 |
COL4A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Porencephaly 2, COL4A2-related disorder |
| RS886039603 |
GOSR2
|
Health Risk |
Likely pathogenic |
— |
| RS886039604 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS886039605 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS886039606 |
MUTYH
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS886039607 |
RAF1
|
Health Risk |
Pathogenic/Likely pathogenic |
LEOPARD syndrome 2, Noonan syndrome 5 |
| RS886039608 |
PRUNE1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with microcephaly, hypotonia |
| RS886039609 |
CHEK2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS886039610 |
PURA
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome |
| RS886039611 |
RTTN
|
Health Risk |
Likely pathogenic |
— |
| RS886039612 |
CDH1
|
Health Risk |
Pathogenic |
Hereditary diffuse gastric adenocarcinoma, 6 conditions |
| RS886039613 |
PALB2
|
Health Risk |
Likely pathogenic |
Familial cancer of breast, Fanconi anemia complementation group N |
| RS886039614 |
PALB2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS886039615 |
PMS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 4 |
| RS886039616 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS886039618 |
APC
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS886039619 |
PALB2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS886039620 |
PALB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS886039621 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS886039623 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |